StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$48.01−0.38 (-0.79%)

Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%

Conmed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Conmed's operating cash flow for the twelve months ending Sep 30, 2026 was $146.31M, down 12.7% year over year. For fiscal 2025 it was $170.69M, up 2.2% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $170.69M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$170.69M+2.2%
FY2024Dec 31, 2024$166.97M+33.2%
FY2023Dec 31, 2023$125.35M+275.7%
FY2022Dec 31, 2022$33.37M-70.1%
FY2021Dec 31, 2021$111.77M+73.2%
FY2020Dec 31, 2020$64.53M-32.2%
FY2019Dec 31, 2019$95.13M+27.4%
FY2018Dec 31, 2018$74.70M+13.9%
FY2017Dec 31, 2017$65.57M+64.4%
FY2016Dec 31, 2016$39.88M-21.7%
FY2015Dec 31, 2015$50.92M-21.9%
FY2014Dec 31, 2014$65.18M-19.5%
FY2013Dec 31, 2013$80.95M-15.0%
FY2012Dec 31, 2012$95.20M-7.6%
FY2011Dec 31, 2011$102.99M+169.3%
FY2010Dec 31, 2010$38.24M+52.8%
FY2009Dec 31, 2009$25.03M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$49.41M-8.0%
Q2 FY2026Jun 30, 2026$37.10M+27.3%
Q1 FY2026Mar 31, 2026$13.47M-67.6%
Q4 FY2025Dec 31, 2025$46.34M+6.9%
Q3 FY2025Sep 30, 2025$53.69M+4.8%
Q2 FY2025Jun 30, 2025$29.13M-32.7%
Q1 FY2025Mar 31, 2025$41.53M+42.6%
Q4 FY2024Dec 31, 2024$43.34M-23.2%
Q3 FY2024Sep 30, 2024$51.20M+11.0%
Q2 FY2024Jun 30, 2024$43.31M+62.4%
Q1 FY2024Mar 31, 2024$29.12M–
Q4 FY2023Dec 31, 2023$56.40M–
Q3 FY2023Sep 30, 2023$46.13M+78.1%
Q2 FY2023Jun 30, 2023$26.67M+42.3%
Q1 FY2023Mar 31, 2023-$3.85M-1272.9%
Q4 FY2022Dec 31, 2022-$11.60M-134.3%
Q3 FY2022Sep 30, 2022$25.89M+21.2%
Q2 FY2022Jun 30, 2022$18.74M-45.3%
Q1 FY2022Mar 31, 2022$328.00K-98.5%
Q4 FY2021Dec 31, 2021$33.79M+67.7%
Q3 FY2021Sep 30, 2021$21.36M-39.2%
Q2 FY2021Jun 30, 2021$34.28M+518.9%
Q1 FY2021Mar 31, 2021$22.34M+500.5%
Q4 FY2020Dec 31, 2020$20.15M-50.7%
Q3 FY2020Sep 30, 2020$35.13M-4.0%
Q2 FY2020Jun 30, 2020$5.54M-74.3%
Q1 FY2020Mar 31, 2020$3.72M–
Q4 FY2019Dec 31, 2019$40.88M+65.5%
Q3 FY2019Sep 30, 2019$36.60M+741.2%
Q2 FY2019Jun 30, 2019$21.58M+4.6%
Q1 FY2019Mar 31, 2019-$3.92M-115.7%
Q4 FY2018Dec 31, 2018$24.70M+18.7%
Q3 FY2018Sep 30, 2018$4.35M-67.6%
Q2 FY2018Jun 30, 2018$20.63M+28.7%
Q1 FY2018Mar 31, 2018$25.02M+63.6%
Q4 FY2017Dec 31, 2017$20.81M+52.0%
Q3 FY2017Sep 30, 2017$13.43M–
Q2 FY2017Jun 30, 2017$16.03M–
Q1 FY2017Mar 31, 2017$15.30M–
Q4 FY2016Dec 31, 2016$13.69M–

More Conmed figures

See a number that looks wrong?